Alaska Permanent Fund’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-160,580
Closed -$25.1M 224
2025
Q1
$25.1M Hold
160,580
0.35% 26
2024
Q4
$23.2M Hold
160,580
0.34% 26
2024
Q3
$26M Hold
160,580
0.38% 25
2024
Q2
$25.3M Buy
160,580
+860
+0.5% +$128K 0.38% 24
2024
Q1
$25.3M Buy
159,720
+2,267
+1% +$361K 0.37% 24
2023
Q4
$24.7M Sell
157,453
-3,590
-2% -$550K 0.41% 27
2023
Q3
$25.1M Sell
161,043
-5,958
-4% -$983K 0.47% 24
2023
Q2
$27.6M Buy
+167,001
New +$27M 0.54% 23
2022
Q4
$17.3M Buy
97,873
+2,006
+2% +$346K 0.28% 27
2022
Q3
$15.7M Buy
95,867
+17,809
+23% +$3.01M 0.28% 22
2022
Q2
$13.9M Buy
78,058
+74,484
+2,084% +$13.3M 0.2% 28
2022
Q1
$634K Buy
3,574
+21
+0.6% +$3.57K 0.01% 218
2021
Q4
$612K Buy
+3,553
New +$582K 0.01% 220

Other funds holding JNJ

Alaska Permanent Fund's JNJ Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 160,580 shares — an estimated $25.1M sold.

Alaska Permanent Fund first reported a position in JNJ in Q4 2021 and held it in 13 quarters. The position peaked at $27.6M in Q2 2023. 4,090 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Alaska Permanent Fund reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 160,580 Johnson & Johnson shares in Q2 2025, an estimated $25.1M.
  • Alaska Permanent Fund first reported a position in Johnson & Johnson in Q4 2021 and held it in 13 quarters.
  • Alaska Permanent Fund's Johnson & Johnson position peaked at $27.6M in Q2 2023.
  • 4,090 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.